Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results
- PMID: 12189557
- PMCID: PMC2376145
- DOI: 10.1038/sj.bjc.6600433
Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results
Abstract
Patients who are treated within clinical trials may have a survival benefit dependent on being a trial participant. A number of factors may produce such beneficial outcome including more rigorous adherence to a peer reviewed trial protocol, management by an experienced treatment team, being treated in a specialist centre etc. The current investigation compared patients treated on and off trial with the same standard arm treatment regimen. The results could then be interpreted without the confounding factors of differing treatment regimens, treatment teams or treatment hospitals. The results demonstrated given these circumstances that survival was no different for patients participating in a randomised trial compared with a group of patients similarly treated who were not eligible for trial entry or who declined randomisation. These results were obtained by the rigorous adherence to a defined protocol with the invaluable assistance of designated lung cancer staff.
Similar articles
-
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).Ann Oncol. 1995 Feb;6(2):157-66. doi: 10.1093/oxfordjournals.annonc.a059111. Ann Oncol. 1995. PMID: 7786823 Clinical Trial.
-
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).Ann Oncol. 1995 Jan;6(1):41-8. doi: 10.1093/oxfordjournals.annonc.a059039. Ann Oncol. 1995. PMID: 7536028 Clinical Trial.
-
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.Ann Oncol. 1991 Jan;2(1):41-6. doi: 10.1093/oxfordjournals.annonc.a057823. Ann Oncol. 1991. PMID: 1848996 Clinical Trial.
-
Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.Lung Cancer. 2001 May;32(2):155-62. doi: 10.1016/s0169-5002(00)00220-8. Lung Cancer. 2001. PMID: 11325486 Review.
-
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.Lung Cancer. 2000 Oct;30(1):23-36. doi: 10.1016/s0169-5002(00)00127-6. Lung Cancer. 2000. PMID: 11008007 Review.
Cited by
-
Comparison of survival outcomes among cancer patients treated in and out of clinical trials.J Natl Cancer Inst. 2014 Mar;106(3):dju002. doi: 10.1093/jnci/dju002. Epub 2014 Mar 13. J Natl Cancer Inst. 2014. PMID: 24627276 Free PMC article.
-
Does enrollment in cancer trials improve survival?J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1. doi: 10.1016/j.jamcollsurg.2012.12.036. Epub 2013 Feb 13. J Am Coll Surg. 2013. PMID: 23415510 Free PMC article.
-
Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trial.J Oncol Pract. 2011 May;7(3):148-53. doi: 10.1200/JOP.2010.000106. J Oncol Pract. 2011. PMID: 21886493 Free PMC article.
-
Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.Cochrane Database Syst Rev. 2008 Jul 16;2008(3):MR000009. doi: 10.1002/14651858.MR000009.pub4. Cochrane Database Syst Rev. 2008. PMID: 18677782 Free PMC article. Review.
-
Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials.Br J Cancer. 2009 Apr 7;100(7):1037-42. doi: 10.1038/sj.bjc.6604982. Epub 2009 Mar 17. Br J Cancer. 2009. PMID: 19293799 Free PMC article.
References
-
- AntmanKAmatoDWoodWCarsonJSuitHProppeKCareyRGreenbergerJWilsonRFreiIIIE1985Selection bias in clinical trials J Clin Oncol 311421147 - PubMed
-
- ArriagadaRLe ChevalierTBorieFRiviereAChomyPMonnetITardivonAViaderFTarayreMBenhamouS1995Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission J Natl Cancer Inst 87183190 - PubMed
-
- AuperinAArriagadaRPignonJ-PLe PechouxCGregorAStephensRJKristjansenPEGJohnsonBEUeokaHWagnerHAisnerJfor the Prophylactic Cranial Irradiation Overview Collaborative Group1999Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission New Eng J Med 341476484 - PubMed
-
- BleehenNMGirlingDJFayersPMAberVRStephensRJ1991Inoperable non -small -cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Counsil by its Lung Cancer Working Party Br J Cancer 63265270 - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical